ストックスクリーナーアプリを入手
0.37
38.84%
-0.235
前日終値:
$0.605
開ける：
$0.6051
24時間の取引高:
7.27M
Relative Volume:
18.60
時価総額：
$38.73M
収益：
$74,000
当期純損益:
$-13.43M
株価収益率:
-0.0394
EPS:
-9.4
ネットキャッシュフロー:
$-10.54M
1週間 パフォーマンス:
-77.30%
1か月 パフォーマンス:
-93.47%
6か月 パフォーマンス:
-93.87%
1年 パフォーマンス:
-98.83%
1日の値動き範囲:
$0.3528
$0.66
1週間の範囲:
$0.3528
$1.74
52週間の値動き範囲:
$0.3528
$39.84
Cyclacel Pharmaceuticals Inc Stock (CYCC) Company Profile
名前
Cyclacel Pharmaceuticals Inc
セクター
電話
908-517-7330
住所
200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
CYCC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CYCC
Cyclacel Pharmaceuticals Inc
|
0.37 | 38.73M | 74,000 | -13.43M | -10.54M | -9.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 113.52B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 52.93B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
300.83 | 39.71B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
585.93 | 35.00B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-07-18 | 再開されました | Oppenheimer | Outperform |
| 2020-04-27 | 再開されました | ROTH Capital | Buy |
| 2018-09-07 | 開始されました | Ladenburg Thalmann | Buy |
| 2015-10-16 | 開始されました | H.C. Wainwright | Buy |
| 2010-02-04 | 開始されました | Roth Capital | Buy |
| 2009-10-28 | 開始されました | Merriman | Buy |
| 2008-08-12 | 開始されました | Piper Jaffray | Buy |
| 2008-03-12 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2008-03-12 | 繰り返されました | Collins Stewart | Buy |
| 2008-03-12 | 繰り返されました | Needham & Co | Buy |
| 2007-11-27 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2007-08-10 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2007-06-04 | 繰り返されました | Needham & Co | Buy |
| 2007-04-23 | 開始されました | Lazard Capital | Buy |
| 2007-04-10 | 開始されました | Cantor Fitzgerald | Buy |
すべてを表示
Cyclacel Pharmaceuticals Inc (CYCC) 最新ニュース
Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Listing Rule - marketscreener.com
Cyclacel Pharmaceuticals Declares Quarterly Cash Dividend - TipRanks
Cyclacel Pharmaceuticals (CYCC) Regains Nasdaq Compliance | CYCC Stock News - GuruFocus
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM - GuruFocus
Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement - marketscreener.com
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT | CYCC Stock News - GuruFocus
Cyclacel Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - Nasdaq
Cyclacel Dodges Delisting Risk: Stock Stabilizes Above $1, Secures Crucial Nasdaq Compliance - Stock Titan
Comparing Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Biodexa Pharmaceuticals (NASDAQ:BDRX) - Defense World
Cyclacel stock plunges to 52-week low of $1.95 amid market challenges - Investing.com Australia
(CYCCP) Proactive Strategies - news.stocktradersdaily.com
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by Analysts at StockNews.com - Defense World
CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE - The Manila Times
Cyclacel Pharmaceuticals Reports Q1 2025 Financial Results and Strategic Focus Shifts to Plogosertib Development - Nasdaq
Upcoming Stock Splits This Week (May 12 to May 16) – Stay Invested - The Globe and Mail
Fitters Clarifies Details Of Business Unit Disposal To Cyclacel - BusinessToday Malaysia
Cyclacel Pharmaceuticals (CYCC) to Release Earnings on Monday - Defense World
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by StockNews.com - Defense World
Trend Tracker for (CYCCP) - news.stocktradersdaily.com
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Shares Scheduled to Reverse Split on Monday, May 12th - Defense World
Cyclacel Pharmaceuticals Announces Reverse Stock Split - TipRanks
Cyclacel Pharmaceuticals (CYCC) Plans 1-for-16 Reverse Stock Split | CYCC Stock News - GuruFocus
Cyclacel Pharmaceuticals Announces Stock Split - marketscreener.com
Cyclacel Pharmaceuticals Announces 1-for-16 Reverse Stock Split Effective May 12, 2025 - Nasdaq
CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT - The Manila Times
Cyclacel Pharmaceuticals enters exchange agreement with Fitters - TipRanks
Cyclacel Pharmaceuticals (CYCC) Plans Strategic Acquisition and Rebranding | CYCC Stock News - GuruFocus
CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCH - GuruFocus
Fitters swaps fire safety arm for 19.99% stake in Nasdaq biotech firm - The Malaysian Reserve
CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN. BHD. ITS WHOLLY-OWNED SUBSIDIARY TO ACCELERATE GROWTH AND STOCKHOLDER VALUE - The Manila Times
CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE - GlobeNewswire
Cyclacel's Major Transformation: 80% Stake in Malaysian Fire Safety Leader Signals Strategic Pivot - Stock Titan
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated by Analysts at StockNews.com - Defense World
Biotech Alert: Searches spiking for these stocks today - TipRanks
Stocks of Cyclacel Pharmaceuticals Inc (CYCC) are poised to climb above their peers - Sete News
Press Release Distribution & PR Platform - ACCESS Newswire
Examining Cyclacel Pharmaceuticals Inc (CYCC) more closely is necessary - uspostnews.com
The Psychology of Cyclacel Pharmaceuticals Inc Inc. (CYCC) Price Performance: Understanding Market Sentiment - investchronicle.com
Cyclacel Pharmaceuticals (CYCC) Announces Quarterly Dividend - GuruFocus
Cyclacel Pharmaceuticals expands share authorization By Investing.com - Investing.com India
Cyclacel Pharmaceuticals expands share authorization - Investing.com
Major Shareholders Set to Sell Stocks; Company (TICKER) to Reap No Proceeds | CYCC Stock News - GuruFocus
Cyclacel Pharmaceuticals Inc Inc. (CYCC) Price Performance: A Technical Analysis Perspective - investchronicle.com
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) Could Actually Go To 1 In 12 Months - Marketing Sentinel
Was Cyclacel Pharmaceuticals Inc (CYCC)’s session last reading good? - uspostnews.com
StockNews.com Initiates Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World
Trading (CYCCP) With Integrated Risk Controls - news.stocktradersdaily.com
Cyclacel Pharmaceuticals announces preferred stock dividend By Investing.com - Investing.com Canada
Cyclacel Pharmaceuticals announces preferred stock dividend - Investing.com
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated at StockNews.com - Defense World
Cyclacel Pharmaceuticals Inc (CYCC) 財務データ
収益
当期純利益
現金流量
EPS
1.21%
1.51%
大文字化:
|
ボリューム (24 時間):